Matches in Nanopublications for { ?s ?p "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP428906.RAZhqcZPqQ0xzUimQaPxeN4zQlH8uZW4tDV9acqczW9vg130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428906.RAZhqcZPqQ0xzUimQaPxeN4zQlH8uZW4tDV9acqczW9vg130_provenance.
- assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP315737.RASyyRTrJGsvVg4rJe9UUIG4OsRRmBrYSkomeuyZKF3QE130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315737.RASyyRTrJGsvVg4rJe9UUIG4OsRRmBrYSkomeuyZKF3QE130_provenance.
- assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP655007.RAdR5eEmE_HJQ-as5mAJPCXuPDoX7QQbuN9dOEyMTRpm8130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655007.RAdR5eEmE_HJQ-as5mAJPCXuPDoX7QQbuN9dOEyMTRpm8130_provenance.
- NP655008.RAdCL0D0j78TBnMAahFdi2HjL8Fr4a8o8IbhukBhBn-0k130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655008.RAdCL0D0j78TBnMAahFdi2HjL8Fr4a8o8IbhukBhBn-0k130_provenance.
- NP655009.RAbvBW1iL7QLfaUR7qjOWgHTv3xXs99Mygbj8s7mcjmTs130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655009.RAbvBW1iL7QLfaUR7qjOWgHTv3xXs99Mygbj8s7mcjmTs130_provenance.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.